Adalat LA 60mg Tablets incorrectly packaged in 30mg carton (CLDA (16)A/08)
Yes – this has been recalled
- The problem
- Quadrant Pharmaceuticals Limited (repackaged by Pharmagen Limited) are asking pharmacists to check stocks of Adalat LA 30mg as there is a possibility that some packs of Parallel Imported LA 60mg may have been incorrectly repackaged.
- What to do
- Check the batch number on your pack against the list below. Do not stop taking a prescribed medicine without talking to your pharmacist, GP or prescriber first – they can check your supply and swap it if needed.
Source: Medicines and Healthcare products Regulatory Agency (MHRA)
Official notice ↗
Product information
CLDA number
CLDA (16)A/08
MDR number
MDR 103-09/16
Company name
Product Licence Holder: Quadrant Pharmaceuticals Limited
Repackaged by: Pharmagen Limited
Product description
Adalat LA 60mg Tablets incorrectly packaged in 30mg carton
PL 20774/1320
Batch number/expiry
- Originator Batch Number: BXH84X5
- Parallel Import Batch Number: IB: C1604
- Expiry date: 08/2019
Brief description of the problem
There is a possibility that some packs of Parallel Imported Adalat LA 60mg Tablets batch BXH84X5 (originator name Adalat Oros 60mg) have been incorrectly repackaged into 30mg cartons.
Pharmacists are asked to check their stock of Adalat LA 30mg Tablets for any packs of batch BXH84X5.
Company contact
If a 30mg carton is found, please contact:
AAH Customer Services
Tel: 0844 561 8899
Updated 29 September 2016. This page summarises an official notice. Details can change – always follow the official notice.